Xtandi 80 MG tab 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FBTJA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,884
Award facts
- Contract value 100% obligated
- $26,884.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $26,884.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 60 tablets of XTANDI 80 mg. This firm fixed-price delivery order was issued on December 19, 2025, with an ultimate completion date of December 22, 2025, and carries no set-aside designation. The award represents a routine procurement action fulfilling Department of Defense pharmaceutical supply requirements through the company's established distribution capabilities.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The underlying IDC, valued at $499,999,999 with a completion date of December 31, 2036, positions DMS Pharmaceutical Group as a critical regional pharmaceutical supplier supporting military healthcare facilities worldwide. The company's performance across numerous delivery orders for diverse pharmaceutical products—including oncology treatments, biologics, vaccines, and specialty medications—demonstrates its capability to serve as a key supplier within the Department of Defense's global pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FBTJA?
SPE2DR26FBTJA was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26FBTJA worth?
The government has obligated $26,884 on SPE2DR26FBTJA.
Is contract SPE2DR26FBTJA an order under another contract?
Yes. SPE2DR26FBTJA is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTJA competed?
The extent of competition for SPE2DR26FBTJA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award